Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...

AstraZeneca CEO Pascal Soriot views the company's stock price — up just 10% year-to-date — as a marker of how he is doing. He ...

An exercise program can reduce the risk that colorectal cancer will return after surgery and chemotherapy, according to a new ...

Budget documents for Congress provide the most detailed look yet at how the Trump Administration hopes to reshape the ...

This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more ...

Researchers estimated 7.5% more U.S. children would get cavities, affecting 25.4 million additional teeth, if fluoridation ...

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

The use of Gilead’s Trodelvy and Merck’s Keytruda together could be practice-changing based on the results of a new study ...

HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...

Amid ongoing uncertainty around funding for the NIH and what it could mean for U.S. innovation, a top Merck executive ...

Harvard's Scott Delaney helped build a database of NIH grant terminations that is being used in litigation against the Trump ...